Abstract: All eukaryotic mRNAs are capped at their 5' end. Capping of mRNAs takes place co-transcriptionally and involves three steps. The intermediates of the capping process, as well as the uncapped 5' tri-phosphate RNA, are resistant to decapping and degradation by known factors, leading to the assumption that the capping process always proceeds to completion. This view was recently drastically changed. A novel family of enzymes, including the yeast proteins Rai1, Dxo1/Ydr370C, and the mammalian protein DXO/Dom3Z, has been identified. These enzymes catalyze the conversion of the improperly capped mRNAs to 5' mono-phosphate RNA, allowing them to be degraded by 5'-3' exoribonucleases. Several of these enzymes also possess 5'-3' exoribonuclease activities themselves, and can single-handedly clear the improperly capped mRNAs. Studying of these enzymes has led to the realization that mRNA capping does not always proceed to completion, and the identification of an mRNA capping quality control mechanism in eukaryotes. In this paper, we briefly review recent advances in this area.
Introduction
All eukaryotic mRNAs are capped at their 5' end, shortly after transcription initiation. The cap consists of a guanine nucleotide methylated at the N 7 position, and is linked to the 5' nucleotide of the RNA through an unusual 5'-5' pyrophosphate linkage (m 7 GpppN) (Shatkin, 1976; Furuichi and Shatkin, 2000) . Capping is crucial for the stability, splicing, polyadenylation, export of mRNA, and their translation efficiency (Merrick, 2004; Meyer et al., 2004; Houseley and Tollervey, 2009; Hocine et al., 2010) . Removal of the cap is a highly regulated process, catalyzed by the decapping enzymes Dcp2 (Dunckley and Parker, 1999; Lykke-Andersen, 2002; Wang et al., 2002; Coller and Parker, 2004) and Nudt16 (Song et al., 2010; Li et al., 2011) . These enzymes release a 7-methyl-guanosine diphosphate molecule from the mRNA, leaving a mono-phosphate at its 5' end. Decapping is followed by RNA degradation by the 5'-3' exoribonuclease Xrn1 (Meyer et al., 2004; Houseley and Tollervey, 2009 ), which recognizes the 5' monophosphate (Stevens, 1978) .
The capping process consists of three steps. First, the tri-phosphate group at the 5' end of the primary transcript is converted to a diphosphate group; second, a GMP molecule is subsequently attached, and finally a mature cap is produced by the methylation of the N 7 atom of the guanosine base (Shuman, 1995; Furuichi and Shatkin, 2000) . In yeast, three distinct enzymes catalyze these reactions, whereas in mammals, the first and second reactions are catalyzed by a bifunctional enzyme (Yue et al., 1997) . The intermediates of the capping process, as well as the uncapped primary transcript, are resistant to degradation by Xrn1, which requires the 5' mono-phosphate (Stevens, 1978 (Coller and Parker, 2004; Song et al., 2010) , and cannot convert them to 5' mono-phosphate RNA for degradation. Therefore, the capping process has been thought to always proceed to completion, as the improperly capped mRNA molecules cannot be cleared by known factors.
Recently, this view has drastically changed. Enzymatic activities have been identified for the yeast protein Rai1, which converts the tri-phosphate group, or the unmethylated cap, at the 5' end of RNA to monophosphate, allowing it to be degraded (Xiang et al., 2009; Jiao et al., 2010) . Such discoveries led to the identification of an mRNA capping quality control mechanism (Jiao et al., 2010) . Thus, we briefly review recent advances in this area.
Discovery of the mechanism
The yeast protein Rai1 (Rat1 interacting protein 1) has been known to bind and stimulate the activity of the 5'-3' exoribonuclease Rat1/Xrn2 (Xue et al., 2000) , which has an important role in polymerase II (Pol II) transcription termination (Kim et al., 2004) . The first 3D structure of Rai1 was determined in complex with Rat1/Xrn2. However, the structure of Rai1 indicated that it possesses some sort of enzymatic activity. A large pocket is found on its surface, away from the Rat1/Xrn2 interacting region (Fig. 1a) . Many conserved residues are concentrated in this region, suggesting that this pocket may serve as an active site. Consistently, subsequent work revealed Rai1 possesses pyrophosphatase activity, which can be attributed to this active site. This activity converts 5' tri-phosphate RNA to 5' mono-phosphate RNA. Like Xrn1, the Rai1 associating exoribonuclease Rat1/ Xrn2 specifically recognizes a 5' mono-phosphate on RNA substrates Stevens and Poole, 1995) , and cannot degrade a 5' tri-phosphate RNA. The identified Rai1 enzymatic activity allows such RNAs to be degraded by the Rai1-Rat1/Xrn2 complex (Xiang et al., 2009) .
The Rai1-Rat1/Xrn2 complex associates with the Pol II mRNA transcription machinery (Kim et al., 2004) . In eukaryotes, the tri-phosphate group at the 5' end of a primary transcript is rapidly converted to an m 7 GpppN cap. These considerations led to the proposal that Rai1 plays a role in mRNA capping quality control, by processing primary transcripts that failed to be capped for degradation (Xiang et al., 2009) .
Following up this clue, subsequent work demonstrated that Rai1 could also convert a capping intermediate, RNAs with an unmethylated cap, to 5' mono-phosphate RNAs for degradation. In a strain defective in cap methylation, knocking out of Rai1 significantly increased the half-life of mRNAs, indicating that inside of the cell Rai1 also plays a central role in clearing improperly capped mRNAs. Importantly, additional work demonstrated that contrary to what was thought, mRNA capping is a regulated process and does not always proceed to completion. Under nutrient starvation conditions, the relative amounts of improperly mRNAs were significantly increased in a Rai1 knock-out strain, despite the fact that the capping machinery was intact. Together, all these evidences identified a quality control mechanism of mRNA capping (Jiao et al., 2010) .
mRNA capping quality control in yeast and mammals
Homologues of Rai1 are found in most eukaryotes (Xue et al., 2000) . Although they only share a moderate sequence similarity, residues corresponding to these in the Rai1 active site are highly conserved (Xiang et al., 2009; Chang et al., 2012; Jiao et al., 2013) . This suggests Rai1 homologues also possess similar enzymatic activities, and the mRNA capping quality control mechanism is conserved in eukaryotes. To date, two such Rai1 homologues have been studied, leading to a further understanding of mRNA capping quality control in yeast, and the confirmation and characterization of such a mechanism in mammals.
Unlike most eukaryotes, which contain only one copy of the Rai1 homologue, in several fugal species including S. cerevisiae, another protein homologous to Rai1 exists (Xue et al., 2000) . This protein, Ydr370C, shares 20% sequence identity with Rai1. Like Rai1, it possesses decapping activities towards RNAs with unmethylated caps. In addition, Ydr370C also has a 5'-3' exoribonuclease activity. These activities enable Ydr370C to degrade RNA molecules with an unmethylated cap single-handedly, and prompted the change of its name to decapping exoribonuclease 1 (Dxo1). Dxo1/Ydr370C does not have any detectable pyrophosphatase activity, unlike Rai1. In normal growth conditions, knocking out either Rai1 or Dxo1/Ydr370C did not cause any detectable changes in mRNA levels. However, knocking them out simultaneously caused a significant increase in the amount of improperly capped mRNA, indicating that both proteins play essential roles in mRNA capping quality control in yeast, and their functions can compensate for each other to some degree (Chang et al., 2012) .
The mammalian Rai1 homologue is Dom3Z. It was found to be a hybrid of Rai1 and Dxo1/Ydr370C, possessing both pyrophosphatase and decapping activities towards RNAs with 5' tri-phosphates or unmethylated caps, as well as a 5'-3' exoribonuclease activity, and its name was subsequently changed to DXO. These activities enable DXO/Dom3Z to singlehandedly degrade uncapped RNAs and RNAs with an unmethylated cap. Knocking down DXO/Dom3Z in cells caused a significant increase in the amount of improperly capped pre-mRNAs, without affecting the levels of mature mRNAs. All these evidences indicate the existence of an mRNA capping quality control mechanism in mammals, in which DXO/Dom3Z plays a central role (Jiao et al., 2013) .
The cellular locations of the Rai1-Rat1/Xrn2 complex, Dxo1/Ydr370C, and DXO/Dom3Z are different. The Rai1-Rat1/Xrn2 is distributed exclusively in the nucleus (Johnson, 1997) , DXO/Dom3Z is mainly found in the nucleus (Zheng et al., 2011) , whereas Dxo1/Ydr370C primarily resides in the cytoplasm (Huh et al., 2003; Chang et al., 2012) . The differences in the cellular localization of these proteins suggest that mRNA capping quality control in mammals takes place inside the nucleus, whereas in yeast, it takes place both inside the nucleus and in the cytoplasm. This difference is probably related to the difference in mRNA export in yeast and mammals. In both organisms, a conserved TREX (transcription/ export) complex plays a central role in mRNA export to the cytoplasm. In yeast, TREX recruitment is coupled to the transcription machinery, whereas the recruitment of the TREX complex is splicing and 5' cap-dependent in mammals (Hocine et al., 2010) . The mammalian mRNA export process therefore acts as an additional checkpoint for mRNA capping, and prevents improperly capped mRNA from entering the cytoplasm. Yeast lacks such a mechanism, which might make additional surveillance for proper capping in the cytoplasm by Dxo1/Ydr370C necessary.
While Rai1 has a minimum decapping activity with regard to mRNAs with mature methylated caps, both Dox1/Ydr370C and DXO/Dom3Z have appreciable decapping activities with regard to this substrate in vitro (Chang et al., 2012; Jiao et al., 2013) . However, inside cells such activity is countered by cap-binding proteins, which preferentially bind to the mature cap and protect it. Consistently, both the nuclear and cytoplasmic cap-binding proteins, CBP20 and elF4E, effectively block this decapping activity of DXO/ Dom3Z in vitro (Jiao et al., 2013) . In addition, DXO/ Dom3Z also possesses a decapping activity towards tri-methylated m 2, 2, 7 GpppN capped RNAs, and may modulate the tri-methyl capped uridylate-rich small nuclear RNAs inside the cell (Jiao et al., 2013) .
Structural insights into the catalysis by Rai1 and its homologues
The structures of Rai1 and its homologues contain two highly twisted β-sheets and several α-helices that cover up some of the exposed surfaces of the β-sheets. The active site is located in the middle of the protein, at the interface between the β-sheets (Xiang et al., 2009; Chang et al., 2012; Jiao et al., 2013) (Fig. 1a) . Four highly conserved sequence motifs are located in the active site, and in DXO/Dom3Z they correspond to residues Arg132 (motif I), Gly188-TyrLys-Phe-Glu192 (motif II, GΦXΦE, where Φ is an aromatic or hydrophobic residue and X is any residue), Glu234-Val-Asp236 (motif III, EhD, where h is a hydrophobic residue), and Glu253-Leu-Lys255 (motif IV, EhK) (Chang et al., 2012; Jiao et al., 2013) . The structures of Rai1 and its homologues are not homologous to any other known protein structures, but have a remote relationship with the structures of D-(D/E)XK nucleases. However, little sequence conservation exists between Rai1 homologues and these nucleases, and the similarity is limited primarily to the aspartate residue in motif III (EhD) and motif IV (EhK), which contribute to the binding of a metal ion in all these enzymes (Chang et al., 2012) .
Mutagenesis studies indicate that the single active site is responsible for all three activities of Rai1 and its homologues: decapping, pyrophosphatase, and 5'-3' exoribonuclease (Xiang et al., 2009; Jiao et al., 2010; Chang et al., 2012; Jiao et al., 2013) . Unlike the decapping enzyme Dcp2, which removes the m 7 Gpp cap from the mRNAs, the decapping activities of Rai1 and its homologues hydrolase the phosphodiester linkage between the first and second nucleotides, releasing methylated or unmethylated GpppN (Jiao et al., 2010; 2013; Chang et al., 2012) .
Structural studies of DXO/Dom3Z provided molecular insights into the catalysis by Rai1 and its homologues. Structures of DXO/Dom3Z in complex with the cap analogue m 7 GpppG (Fig. 1b) and oligonucleotides (Fig. 1c) indicate that a capped mRNA molecule binds across the active site pocket, with the cap and the first nucleotide (m 7 GpppN) at one side and the rest of the RNA molecule at the opposite side, and the catalytic machinery consists of two metal ions, located in the middle. The side-chain of Arg132 (motif I) recognizes a phosphate group on the cap and the catalytic metal ions are coordinated by side-chains of residues in motifs II, III, and IV, the phosphate group between the first and second nucleotides, as well as the main chain carbonyl of Leu254 in motif IV. Based on the structural information, it was proposed that one of the metal ions activates a water molecule or a hydroxyl ion, which subsequently attacks the scissile phosphate between the first and second nucleotides, making a cleavage 5' to this group and releasing GpppN. The side-chain of Lys255 (motif IV) stabilizes the oxyanion intermediate in the catalysis (Jiao et al., 2013) (Fig. 1d) . This two-metal-ion catalysis is also widely employed by many nucleases (Yang, 2011) .
Structures of DXO/Dom3Z indicate the active site region that binds the cap and the first nucleotide can also accommodate a 5' end nucleotide (pN 1 ) or a pyrophosphate group, and the catalysis on 5' monophosphate or 5' tri-phosphate RNAs releases pN 1 or the pyrophosphate group, giving rise to the 5'-3' exoribonuclease and pyrophosphatase activities. Therefore, the three seemingly distinct activities of Rai1 and its homologues all utilize the same catalytic machinery, and the outcome of the catalysis is dictated by the different binding modes of different substrates (Jiao et al., 2013) .
Concluding remarks
Contrary to what had been thought, it is now known that the eukaryotic mRNA capping process does not always proceed to completion. Improperly capped mRNAs might be caused by sporadic errors in the capping process, and the capping quality control mechanism corrects these errors. And/or, as emerging evidence suggests, this is the result of active regulation to mRNA capping. For instance, it has been reported that importin-α stimulates general cap methylation (Wen and Shatkin, 2000) , Myc regulates the cap methylation of many mRNAs (Cowling and Cole, 2007; 2010; Cowling, 2010) , and nutrient starvation caused a general decrease in cap methylation (Jiao et al., 2010) . The regulatory factors of mRNA capping, together with the capping quality control mechanism, might provide yet another layer of regulation to gene expression.
Recent studies have greatly advanced our understanding of mRNA capping quality control in eukaryotes. However, our current understanding of this process is far from complete. For instance, the molecular basis for the differences in the substrate specificities of Rai1, Dxo1/Ydr370C, and DXO/Dom3Z remains obscure; whether a 5' di-phosphate RNA, another intermediate generated in the capping process, can be cleared by currently known capping quality control factors remains to be seen. Importantly, little is known about how Rai1 and its homologues interact with other factors, to coordinate capping quality control with other cellular processes. For instance, in yeast it has been shown that the Rai1-Rat1/Xrn2 complex associates with the Pol II transcription machinery (Kim et al., 2004) , and Rat1/Xrn2 degrades the improperly capped nascent transcripts cotranscriptionally (Jimeno-Gonzalez et al., 2010) . It remains to be seen whether in mammalian cells DXO/Dom3Z also associates with the transcription machinery and, if so, what factors are responsible for its recruitment. Further studies are necessary to answer these questions.
The mRNA cap has important functions in many cellular processes, and the identification of the capping quality control mechanism provides a novel method to perturb the cap structure and to probe the function of the cap in these processes. This is exemplified by the knocking down studies of DXO/Dom3Z, which has led to the realization that in mammalian cells the mRNA cap is more intimately linked to mRNA splicing and polyadenylation than previously thought (Jiao et al., 2013) . Further studies in this direction will bring a better understanding of the physiological role of the mRNA cap.
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